This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 February - 5 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza and influenza A(H5N1) , Middle East respiratory syndrome coronavirus (MERS-CoV), Mpox, poliomyelitis, Marburg virus disease and the Earthquakes in Türkiye, Syria.
Immediate health needs following earthquakes in Türkiye and Syria are mostly related to trauma and the disruption of healthcare, however, infectious disease threats may be concerning in the following two to four weeks.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
In 2019, a total of 117 881 confirmed cases of gonorrhoea were reported by 28 EU/EEA Member States. The overall crude notification rate was 31.6 cases per 100 000 population.
In 2021, 14 560 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases the number of cases (14 550 cases) corresponds to a crude rate of 4.1 cases per 100 000 population.
This issue of the Communicable Disease Threats Report (CDTR) covers the period 23-29 January 2023 and includes updates on COVID-19, diphtheriae, influenza, chikungunya, dengue and poliomyelitis.